ATE857T1 - Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine. - Google Patents
Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine.Info
- Publication number
- ATE857T1 ATE857T1 AT79104391T AT79104391T ATE857T1 AT E857 T1 ATE857 T1 AT E857T1 AT 79104391 T AT79104391 T AT 79104391T AT 79104391 T AT79104391 T AT 79104391T AT E857 T1 ATE857 T1 AT E857T1
- Authority
- AT
- Austria
- Prior art keywords
- membrane proteins
- neisseria meningitidis
- production
- vaccine containing
- optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782848965 DE2848965A1 (de) | 1978-11-11 | 1978-11-11 | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
EP79104391A EP0011243B1 (fr) | 1978-11-11 | 1979-11-08 | Procédé de production de protéines membranaires de Neisseria meningitidis et vaccins les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE857T1 true ATE857T1 (de) | 1982-04-15 |
Family
ID=6054405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT79104391T ATE857T1 (de) | 1978-11-11 | 1979-11-08 | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0011243B1 (fr) |
JP (1) | JPS5566519A (fr) |
AT (1) | ATE857T1 (fr) |
AU (1) | AU533386B2 (fr) |
CA (1) | CA1142083A (fr) |
DE (2) | DE2848965A1 (fr) |
DK (1) | DK154841C (fr) |
ES (1) | ES485715A1 (fr) |
IL (1) | IL58673A (fr) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU563317B2 (en) * | 1982-12-02 | 1987-07-02 | Rockefeller University, The | Iga binding antibody |
US7118757B1 (en) | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
ES2278446T3 (es) | 1998-05-29 | 2007-08-01 | Novartis Vaccines And Diagnostics, Inc. | Vacunas combinadas b/c contra la meningitis. |
MXPA01011867A (es) | 1999-05-19 | 2002-05-06 | Chiron Spa | Composiciones neisseriales de combinacion. |
GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
EP2275129A3 (fr) | 2000-01-17 | 2013-11-06 | Novartis Vaccines and Diagnostics S.r.l. | Vaccin omv complèté contre la méningocoque |
GB0103171D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
EP2255826B1 (fr) | 2002-08-02 | 2016-04-13 | GlaxoSmithKline Biologicals S.A. | Composition vaccinale comprenant une combinaison d'antigenes de neisseria |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
CU23313A1 (es) | 2002-11-27 | 2008-09-25 | Inst Finlay Ct De Investigacia | Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios |
GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
EP1706481A2 (fr) * | 2003-12-23 | 2006-10-04 | GlaxoSmithKline Biologicals S.A. | Vaccin |
GB0419627D0 (en) | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
JP5275983B2 (ja) | 2006-06-12 | 2013-08-28 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
CN101951949B (zh) | 2007-10-19 | 2013-10-02 | 诺华股份有限公司 | 脑膜炎球菌疫苗制剂 |
EP3263591B1 (fr) | 2008-02-21 | 2019-03-27 | GlaxoSmithKline Biologicals S.A. | Polypeptides fhbp méningococciques |
GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
WO2010070453A2 (fr) | 2008-12-17 | 2010-06-24 | Novartis Ag | Vaccins méningococciques comprenant un récepteur de l'hémoglobine |
WO2010144734A1 (fr) | 2009-06-10 | 2010-12-16 | Novartis Ag | Vaccins contenant de la benzonaphtyridine |
EP2470204B1 (fr) | 2009-08-27 | 2015-12-16 | GlaxoSmithKline Biologicals SA | Polypeptides hybrides contenant des séquences fhbp à méningocoques |
WO2011024071A1 (fr) | 2009-08-27 | 2011-03-03 | Novartis Ag | Adjuvant contenant de l'aluminium, un oligonucléotide et une polycation |
TWI445708B (zh) | 2009-09-02 | 2014-07-21 | Irm Llc | 作為tlr活性調節劑之化合物及組合物 |
GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
AU2010302344A1 (en) | 2009-09-30 | 2012-04-26 | Novartis Ag | Expression of meningococcal fhbp polypeptides |
MX2012004850A (es) | 2009-10-27 | 2012-05-22 | Novartis Ag | Polipeptidos fhbp meningococicos modificados. |
WO2011057148A1 (fr) | 2009-11-05 | 2011-05-12 | Irm Llc | Composés et compositions permettant de moduler l'activité des tlr-7 |
CN102762206A (zh) | 2009-12-15 | 2012-10-31 | 诺华有限公司 | 免疫增强化合物的均匀悬液及其用途 |
CN103002910A (zh) | 2010-03-10 | 2013-03-27 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗组合物 |
EP2547357A1 (fr) | 2010-03-18 | 2013-01-23 | Novartis AG | Vaccins adjuvantés contre le méningocoque de sérogroupe b |
EA023725B1 (ru) | 2010-03-23 | 2016-07-29 | Новартис Аг | Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний |
WO2012032498A2 (fr) | 2010-09-10 | 2012-03-15 | Novartis Ag | Développements apportés à des vésicules membranaires externes méningococciques |
GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
EP2707009A1 (fr) | 2011-05-12 | 2014-03-19 | Novartis AG | Antipyrétiques pour améliorer la tolérabilité de vaccins à base de vésicules |
AU2013214105A1 (en) | 2012-02-02 | 2014-07-24 | Novartis Ag | Promoters for increased protein expression in meningococcus |
US10598666B2 (en) | 2012-03-08 | 2020-03-24 | Glaxosmithkline Biologicals Sa | In vitro potency assay for protein-based meningococcal vaccines |
US10376573B2 (en) | 2012-06-14 | 2019-08-13 | Glaxosmithkline Biologicals Sa | Vaccines for serogroup X meningococcus |
US9526776B2 (en) | 2012-09-06 | 2016-12-27 | Glaxosmithkline Biologicals Sa | Combination vaccines with serogroup B meningococcus and D/T/P |
MX363529B (es) | 2012-09-18 | 2019-03-27 | Novartis Ag | Vesículas de membrana externa. |
KR20160127104A (ko) | 2014-02-28 | 2016-11-02 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 변형된 수막구균 fhbp 폴리펩티드 |
US20180064801A1 (en) | 2016-09-02 | 2018-03-08 | Glaxosmithkline Biologicals Sa | Vaccines for neisseria gonorrhoeae |
EP3607967A1 (fr) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Polypeptides modifiés du méningocoque fhbp |
BR112021007668A2 (pt) | 2018-11-06 | 2021-07-27 | Glaxosmithkline Biologicals S.A. | composições imunogênicas |
EP3799884A1 (fr) | 2019-10-01 | 2021-04-07 | GlaxoSmithKline Biologicals S.A. | Compositions immunogènes |
GB202115072D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
GB202115077D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
GB202211033D0 (en) | 2022-07-28 | 2022-09-14 | Glaxosmithkline Biologicals Sa | Purification process |
-
1978
- 1978-11-11 DE DE19782848965 patent/DE2848965A1/de not_active Withdrawn
-
1979
- 1979-11-06 ES ES485715A patent/ES485715A1/es not_active Expired
- 1979-11-08 DE DE7979104391T patent/DE2962526D1/de not_active Expired
- 1979-11-08 AT AT79104391T patent/ATE857T1/de not_active IP Right Cessation
- 1979-11-08 EP EP79104391A patent/EP0011243B1/fr not_active Expired
- 1979-11-09 AU AU52682/79A patent/AU533386B2/en not_active Ceased
- 1979-11-09 JP JP14456179A patent/JPS5566519A/ja active Granted
- 1979-11-09 DK DK475779A patent/DK154841C/da not_active IP Right Cessation
- 1979-11-09 CA CA000339541A patent/CA1142083A/fr not_active Expired
- 1979-11-09 IL IL58673A patent/IL58673A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE2962526D1 (en) | 1982-05-27 |
JPS6350332B2 (fr) | 1988-10-07 |
CA1142083A (fr) | 1983-03-01 |
DK475779A (da) | 1980-05-12 |
EP0011243A1 (fr) | 1980-05-28 |
AU533386B2 (en) | 1983-11-24 |
ES485715A1 (es) | 1980-05-16 |
JPS5566519A (en) | 1980-05-20 |
IL58673A0 (en) | 1980-02-29 |
IL58673A (en) | 1983-02-23 |
DK154841B (da) | 1988-12-27 |
DE2848965A1 (de) | 1980-05-22 |
AU5268279A (en) | 1980-05-15 |
EP0011243B1 (fr) | 1982-04-14 |
DK154841C (da) | 1989-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE857T1 (de) | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine. | |
ATE195420T1 (de) | Methode zur herstellung von eicosapentansäuren | |
DE3767077D1 (de) | Verfahren zur abtrennung von cholesterin aus fettsubstanzen tierischen ursprungs und cholesterinarme fettsubstanzen. | |
DE69224124D1 (de) | Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid | |
ATE944T1 (de) | Verfahren zur herstellung von knochenersatzmaterial mit verbesserter biologischer stabilitaet auf der basis von kollagen und das erhaltene knochenersatzmaterial. | |
DE60107446D1 (de) | Gereinigtes cochinealpigment und verfahren zur herstellung desselben | |
ATE123947T1 (de) | Echinacea-extrakte, verfahren zur herstellung und zubereitungen, die sie enthalten. | |
ATE24475T1 (de) | Verfahren zur reinigung eines gemisches von wasser mit c1-c2-alkoholen das von der industriellen herstellung von ethanol stammt, mit hilfe eines extraktionsmittels. | |
ATE72756T1 (de) | Verfahren zur herstellung eines biologischen stoffes. | |
ATE52890T1 (de) | Verfahren und vorrichtung zur verbesserung von roestkaffee. | |
ATA7285A (de) | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) | |
EP0607593A3 (fr) | Procédé d'obtention de cultures cellulaires avec un taux amélioré de cytonines autogènes. | |
ATE30161T1 (de) | Verfahren zur herstellung von globin aus haemoglobin und das in diesem verfahren erhaltene globin. | |
ATE91304T1 (de) | Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe. | |
ATE100148T1 (de) | Verfahren zur herstellung von hochgradig ungesaettigten fettsaeuren. | |
ATE116989T1 (de) | Verfahren zur reinigung von hemin, neues heminderivat und verfahren zur herstellung. | |
ATE14596T1 (de) | Verfahren zur herstellung von ammoniumlactat enthaltenden mischungen und vorrichtung zur durchfuehrung des verfahrens. | |
ATE70452T1 (de) | Verfahren zur herstellung eines propolis|thanolextraktes. | |
DE69033833D1 (de) | Verfahren zur Herstellung von Butantetracarbonsäure | |
FR2620726B1 (fr) | Procede de preparation d'un extrait de jasmin et extrait obtenu | |
ATE215784T1 (de) | Verfahren zur herstellung eines kappa-casein- glykomakropeptides oder eines abkoemmlings davon | |
FR2429765A1 (fr) | Procede et agent d'adsorption pour isoler des enzymes et pour les preparer a l'etat pur | |
ATE69034T1 (de) | Verfahren zur herstellung von polychlorophosphazen. | |
DE59106227D1 (de) | Verfahren zur herstellung von spagyrischen essenzen aus pflanzen. | |
JPS6410950A (en) | Elimination of taste and odor of substance rich in amino acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEIH | Change in the person of patent owner | ||
EELA | Cancelled due to lapse of time |